Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

Pacific Specialist Healthcare has performed Fiji’s first open-heart surgery, achieving a 100 percent success rate and ...

In what could one day become a new treatment for epilepsy, researchers at UC San Francisco, UC Santa Cruz and UC Berkeley have used pulses of light to prevent seizure-like activity in neurons.

Researchers at Helmholtz Munich, in collaboration with colleagues at Tohoku University, have identified a specific redox protein as a critical regulator of ferroptosis - a form of regulated oxidative ...

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...

A drug-eluting contact lens that uses 3D printing technology can improve IOP and treatment compliance for patients with glaucoma.

Sharma underwent surgery yesterday for cataract shared his experience to raise awareness about the importance of early ...